MedDataToolMedDataTool

Spiriva Respimat

Generic: Tiotropium Bromide Inhalation Spray

Rx only
Anticholinergic✓ FDA-verified
View full FDA label ↗
Spiriva Respimat is a medication used for the long-term treatment of chronic obstructive pulmonary disease (COPD) and asthma in patients aged 6 and older. It works by relaxing the muscles in the airways, helping to open them up and making it easier to breathe. You take it by inhaling two puffs once a day, with the starting dose for COPD being 2.5 mcg and for asthma being 1.25 mcg, and you should not exceed this daily amount. It's important to know that Spiriva Respimat is not meant for quick relief of sudden breathing problems. If you have kidney issues, you should be monitored closely while using this medication.
✦

Uses

  • Chronic obstructive pulmonary disease (COPD).
  • Asthma in patients 6 years and older.
◷

Dosage

2 inhalations of SPIRIVA RESPIMAT 2.5 mcg once daily for COPD. 2 inhalations of SPIRIVA RESPIMAT 1.25 mcg once daily for asthma.
No dosage adjustment for elderly or patients with liver or kidney issues.
If not used for more than 3 days, actuate inhaler once before use.
If not used for more than 21 days, prime inhaler before use.
Always follow your doctor's specific instructions for your dose.
⚠

Side effects

Common

pharyngitiscoughdry mouthsinusitishypersensitivity reactions

Serious

paradoxical bronchospasmworsening of glaucomaurinary retention
🛑

Warnings

⚠ Important warnings

  • Not for relief of acute bronchospasm.
  • Monitor closely in patients with moderate to severe renal impairment.
  • Avoid with other anticholinergic medications.
⇄

Drug interactions

  • Anticholinergicsmay increase side effectsCaution
  • Cimetidineincreases tiotropium levelsMonitor
  • Ranitidineno significant effect on tiotropiumCaution

Ask about this drug

Answers pulled from the FDA label only.

AI
Medical Disclaimer: This content is provided for informational and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before taking any medication.
Data Source: Publicly available drug labeling information from the U.S. Food and Drug Administration (FDA).